HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mary Anne Dellva Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

1/2024Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion.
11/2023Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials.
1/2023Efficacy and safety of ultra-rapid lispro versus lispro in children and adolescents with type 1 diabetes: The PRONTO-Peds trial.
1/2022Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study.
11/2021Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog® Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data.
12/2020Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial.
10/2020Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.
10/2020Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mary Anne Dellva Research Topics

Disease

8Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2024 - 10/2020
6Major Depressive Disorder (Major Depressive Disorders)
05/2016 - 04/2010
4Type 2 Diabetes Mellitus (MODY)
11/2023 - 12/2020
3Injection Site Reaction
01/2023 - 10/2020
2Nausea
01/2014 - 04/2010
2Psychotic Disorders (Schizoaffective Disorder)
04/2010 - 08/2007
2Schizophrenia (Dementia Praecox)
04/2010 - 08/2007
1Hyperhidrosis
01/2014
1Erectile Dysfunction
01/2014
1Fatigue
01/2014
1Pain (Aches)
01/2014
1Bipolar Disorder (Manic Depressive Psychosis)
04/2010
1Constipation
04/2010
1Dementia (Dementias)
04/2010
1Headache (Headaches)
04/2010
1Sleep Initiation and Maintenance Disorders (Insomnia)
04/2010
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
03/2007

Drug/Important Bio-Agent (IBA)

11Insulin Lispro (Humalog)FDA Link
01/2024 - 10/2020
6alpha- ((5- fluoro- 2- methoxyphenyl)methyl)- alpha- (tetrahydro- 2H- pyran- 4- yl)- 2- morpholinemethanolIBA
05/2016 - 04/2010
5Norepinephrine (Noradrenaline)FDA LinkGeneric
05/2016 - 04/2010
4Glucose (Dextrose)FDA LinkGeneric
11/2023 - 10/2020
4Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
05/2016 - 01/2014
2Antidepressive Agents (Antidepressants)IBA
06/2015 - 01/2015
1Insulin (Novolin)FDA Link
01/2024
1SuspensionsIBA
01/2024
1Hemoglobins (Hemoglobin)IBA
11/2023
1Olanzapine (Zyprexa)FDA Link
04/2010
1Antipsychotic Agents (Antipsychotics)IBA
08/2007
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
03/2007

Therapy/Procedure

2Therapeutics
05/2016 - 06/2015
1Injections
11/2023
1Duration of Therapy
08/2007